Abstract
Humans have tried to fight diseases by the usage of vaccines. Vaccination is a powerful and cost-effective weapon for the prevention of diseases. Because of worldwide vaccination programs, the humans have not only successfully used vaccines to get rid of many childhood diseases but also some of the diseases like smallpox are completely eradicated. Any preparation of virus, bacteria, or their subunits, which is able to impart protection in the individual in which they are administered by activating the immune system, is known as vaccine. As immunization drive starts from childhood therefore it has substantially lowered the morbidity and mortality of children from many infectious diseases.
Vaccination is a mode of active immunization in which attenuated live microorganism or killed microorganism or its specific component is administered in humans. Following exposure to modified pathogenic agent (not able to harm and cause diseases in humans), the immune system is activated. Immune systems’ innate and adaptive branches effectively neutralize the pathogenic agents and its T and B cells owing to their memory response remember their first encounter with the pathogen. Upon subsequent encounter in the due course of time with the same agent, the immune systems’ adaptive branch (T- and B-cell response) effectively and quickly mounts a heightened response and facilitates antigen clearance from the body.
However, despite of tremendous developments in science and technology, some diseases (AIDS, malaria, multiple drug-resistant TB, leishmaniasis) are still big challenges for which we do not have effective vaccines. Vaccines need to be developed for these diseases, which are cause of millions of death worldwide. The chapter is designed to give the insights about the properties of vaccines, adjuvants, attenuated, inactivated, subunit, and nucleic acids as vaccines. This also covers edible vaccines, vaccination for cancer, reverse vaccinology, and generation of vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas AK, Lichtman AH (2009) Basic immunology, 3rd edn. Saunders Elsevier, Philadelphia
Alm, Gunner V (2003) Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36:463–472
Decatris, Marios (2002) Potential of interferon-alfa in solid tumours. Biodrugs 16:261–268
Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 110:525–541
Fleur NS (2015) Inhaled ebola vaccine stops virus in monkeys, Study finds. The New York Times (July 13)
Goodsell, David S (2001) The molecular perspective: interferon. Oncologist 6:374–375
IIchmann K et al (n.d.) Vaccine development & the BWC. http://hsp.sussex.ac.uk/sandreviews/
Kindt TJ, Goldsby RA, Osborne B (2007) KUBY immunology, 6th edn. Freeman and Company, New York
Kit Y-Y, Semenov DV, Nevinsky GA (1996) Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem Mol Biol Int 39:521–527
Korban SS, Krasnyanski SF, Buetow DE (2002) Foods as production and delivery vehicles for human vaccines. J Am Coll Nutr 21:212S–217S
Krensky AM, Flavio V, Bennett WM (n.d.) Chapter 52. Immunosuppressants, tolerogens, and immunostimulants. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn: http://www.accessmedicine.com/content.aspx?aID=951722
Liu M (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239:62–84
Lollini PL, Cavallo F, Nanni P, Forni G (2006) Vaccines for tumour prevention. Nat Rev Cancer 6:204–216
Lowy DR, Schiller JT (2006) Prophylactic human papillomavirus vaccines. J Clin Invest 116:1167–1173
Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, Masignani V (2008) Genome-based vaccine development a short cut for the future. Hum Vaccin 4:184–188
Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044
Scheibner V (1993) Vaccinations 100 years of orthodox research. New Altantean Press, Santa Fe
Semiromi AD, Samson N, Daniell H (2009) The green vaccine: a global strategy to combat infectious and autoimmune diseases. Hum Vaccine 5:488–493
U.S. Centers for Disease Control and Prevention (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents. Morb Mortal Wkly Rep 54(No. RR–16):1–31
World Health Organisation (2006) Development of new vaccines. Fact Sheet no 289, Revised December 2006
Some Selected Resources
immunostimulants.blogspot.com
www.cdc.gov/vaccines/events/niiw/ed-resources/partner-resources.html
www.cdc.gov/vaccines/hcp/patient-ed/conversations/index.html
www.dshs.state.tx.us › Immunization Branch
www.vaccines.gov › More info › Guide to vaccines websites
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Gupta, V., Sengupta, M., Prakash, J., Tripathy, B.C. (2017). Vaccine. In: Basic and Applied Aspects of Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-10-0875-7_14
Download citation
DOI: https://doi.org/10.1007/978-981-10-0875-7_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0873-3
Online ISBN: 978-981-10-0875-7
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)